Evaluation of Pain Regression in Patients With Myofascial Facial Pain Using Dextrose, Local Anaesthesia and Saline.

Sponsor
Cairo University (Other)
Overall Status
Unknown status
CT.gov ID
NCT03161210
Collaborator
(none)
80
3
7

Study Details

Study Description

Brief Summary

The aim of this study is to compare the treatment effects of dextrose prolotherapy, saline, and mepivacaine for deactivating myofascial trigger points within the jaw muscles.

Condition or Disease Intervention/Treatment Phase
  • Other: Dextrose Prolotherapy
  • Other: Local Anaesthesia
  • Other: Saline
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Evaluation of Pain Regression in Patients With Myofascial Facial Pain Treated by Dextrose Prolotherapy Versus Local Anesthetic Injections: A Prospective Double-blind Randomized Placebo-controlled Clinical Trial.
Anticipated Study Start Date :
Sep 1, 2017
Anticipated Primary Completion Date :
Dec 1, 2017
Anticipated Study Completion Date :
Apr 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Dextrose Prolotherapy

Other: Dextrose Prolotherapy
Dextrose is a solution, mixture of dextrose and water.

Active Comparator: Local Anaesthetic

Other: Local Anaesthesia
A local anaesthetic is a medication that causes reversible absence of pain sensation

Placebo Comparator: Saline

Other: Saline
Saline is a control group

Outcome Measures

Primary Outcome Measures

  1. Patients' subjective pain experience [one year]

    Pressure pain threshold (PPT): An algometer will be used to assess PPT. The algometer consists of a 1 cm2 rubber tipped plunger mounted on a force transducer. The pressure will be applied over the examined trigger point. The participants will be instructed to point when the sensation changed from pressure to pain. The mean of three trials will be calculated and used for analysis.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
    1. Presence of active myofacial pains in jaw muscles, previously identified by manual palpation.
  1. Age ≥ 18 years. 3. Willingness to follow instructions
Exclusion Criteria:
    1. Therapeutic intervention for myofascial pain within the past month before the study, such as using of medications for pain control or wearing of occlusal splint.
  1. Clinical conditions such as pregnancy. 3. Medical problems that may interfere with the procedures such as bleeding disorders, trigeminal neuralgia.

  2. Recent facial or neck trauma; medication or adjunctive treatment (eg, physiotherapy) that could not be stopped during the study; or allergy to local anesthetic solutions.

  3. Cognitive impairment or exhibited inadequate cooperation.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Cairo University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Alaa Ahmed Mohamed Ammar, Principal Investigator, Internal resident in Oral and Maxillofacial Department, faculty of oral and dental medicine., Cairo University
ClinicalTrials.gov Identifier:
NCT03161210
Other Study ID Numbers:
  • 28712038800227
First Posted:
May 19, 2017
Last Update Posted:
May 22, 2017
Last Verified:
May 1, 2017
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 22, 2017